ROYAL BANK OF CANADA - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 18 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$42,000
+425.0%
3,582
+410.3%
0.00%
Q1 2024$8,000
-93.3%
702
-92.8%
0.00%
Q4 2023$120,000
+192.7%
9,790
+131.7%
0.00%
Q3 2023$41,000
+2.5%
4,226
-5.9%
0.00%
Q2 2023$40,000
+263.6%
4,492
+225.7%
0.00%
Q1 2023$11,000
-62.1%
1,379
-68.2%
0.00%
Q4 2022$29,000
-79.7%
4,332
-56.0%
0.00%
Q3 2022$143,000
+14200.0%
9,847
+7035.5%
0.00%
Q2 2022$1,000
-95.0%
138
-90.0%
0.00%
Q1 2022$20,000
-69.7%
1,376
-72.3%
0.00%
Q4 2021$66,000
+61.0%
4,971
+113.8%
0.00%
Q3 2021$41,000
-41.4%
2,325
-19.8%
0.00%
Q2 2021$70,000
+52.2%
2,900
+62.2%
0.00%
Q1 2021$46,000
+253.8%
1,788
+166.9%
0.00%
Q4 2020$13,000670
+3090.5%
0.00%
Q3 2020$021
-34.4%
0.00%
Q1 2020$0
-100.0%
32
-97.5%
0.00%
Q4 2019$22,0001,263
+12530.0%
0.00%
Q3 2018$010
+900.0%
0.00%
Q1 2017$010.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,579,490$20,146,00022.25%
Novo Holdings A/S 2,901,927$22,664,0002.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 322,436$2,518,0000.96%
Vivo Capital, LLC 300,325$2,346,0000.69%
VHCP Management II, LLC 221,651$1,635,0000.67%
RA Capital Management 591,070$4,616,0000.57%
INTERWEST VENTURE MANAGEMENT CO 329,942$2,577,0000.55%
Eventide Asset Management 98,100$766,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 21,665$169,0000.03%
A.R.T. Advisors, LLC 11,116$86,0000.00%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders